ATLANTA, July 30, 2012 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its second quarter fiscal year 2012 financial results after the market close on Thursday, August 9, 2012. An investor conference call will follow on the same day at 4:30 p.m. ET.
